Just-In-Time (JIT) Core Usage Funding Program
The Just-In-Time (JIT) Core Usage Funding Program is designed to provide quick access to funding to use any of the JIT Cores for research advancing medical knowledge that can improve human health. The program provides support for investigators in obtaining final data that: Find out more and apply on the Institute of Clinical and Translational Scienc
Dr. Hussein Sultan wins 2023 Presidential Travel Award from SITC (Links to an external site)
DiPersio Lab graduate student receives Minority Hematology Graduate Award from ASH (Links to an external site)
New “Mega” mouse kit available by ThermoFisher Scientific
Dr. Ali Ellebedy and multi-institution, multidisciplinary team awarded $13M by NIH to develop better vaccines against coronaviruses (Links to an external site)
The National Institute of Allergy and Infectious Diseases has awarded the Icahn School of Medicine at Mount Sinai a five-year, $13 million grant to bring together experts from multiple disciplines across five research institutions to create better vaccines against current as well as emerging coronaviruses. The “Programming Long-lasting Immunity to Coronaviruses” (PLUTO) project will be […]
Dr. Gwendalyn Randolph selected for new National Commission for Lymphatic Diseases (Links to an external site)
Gwendalyn Randolph, PhD, Emil R. Unanue Professor of Pathology and Immunology in the Division of Immunobiology, was chosen to be a member of the newly formed National Commission for Lymphatic Diseases. The Commission, which is slated for an inaugural meeting in December 2023, will be convened by NHLBI leadership. In 2022, Congress directed the NIH to […]
Siteman earns prestigious merit extension from National Cancer Institute (Links to an external site)
Dr. Ann Gronowski named to The Pathologist Power List (Links to an external site)
BioLegend Summer Sale
COVID-19 vaccine elicits antibodies in 90% taking immunosuppressants (Links to an external site)
COVID-19 vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their responses were only about one-third as strong as those mounted by healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.